Primoris (PRIM) director receives $37,500 restricted stock grant

Rhea-AI Filing Summary

MASHINSKI CARLA S reported acquisition or exercise transactions in this Form 4 filing.

Primoris Services Corp director Carla S. Mashinski received a grant of 294 shares of common stock under the company’s non-employee director compensation program. The award has a stated value of $37,500, with the share price based on the average closing price during December 2025. After this grant, she holds 21,824 shares directly, and the granted shares cannot be sold for twelve months from the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MASHINSKI CARLA S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	294	$0.00	--

Holdings After Transaction: Common Stock — 21,824 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MASHINSKI CARLA S

(Last) (First) (Middle)

C/O PRIMORIS SERVICES CORPORATION

2300 N. FIELD STREET, SUITE 1900

(Street)

DALLAS TX 75201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Primoris Services Corp [ PRIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A		294	A	(1)	21,824	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024, provides for the issuance of restricted stock with a value of $37,500. The price per share was based on the average closing price during December 2025, resulting in a grant of 294 shares of stock. The shares of stock cannot be sold for a period of twelve months from the date of grant.

	/s/ Kenneth M. Dodgen, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Primoris (PRIM) report for Carla S. Mashinski?

Primoris reported that director Carla S. Mashinski received a grant of 294 shares of common stock. The shares were issued as part of the non-employee director compensation program and represent equity-based compensation rather than an open-market stock purchase.

What is the value of the Primoris (PRIM) stock grant to Carla S. Mashinski?

The stock grant to Carla S. Mashinski has a stated value of $37,500. This value comes from Primoris’s non-employee director compensation program, which specifies restricted stock awards with that dollar amount for eligible directors as part of their annual compensation.

How many Primoris (PRIM) shares did Carla S. Mashinski hold after the Form 4 transaction?

After the grant of 294 shares, Carla S. Mashinski directly owned 21,824 shares of Primoris common stock. This total reflects her holdings immediately following the reported equity award and shows the updated size of her direct ownership position.

How was the share price determined for Carla S. Mashinski’s Primoris (PRIM) stock grant?

The share price for the grant was based on the average closing price of Primoris stock during December 2025. That average price was used to translate the $37,500 award value into 294 shares of common stock under the compensation program.

Are there restrictions on when Carla S. Mashinski can sell the granted Primoris (PRIM) shares?

Yes. The 294 granted shares cannot be sold for twelve months from the grant date. This holding period requirement is part of the non-employee director compensation program’s terms for restricted stock issued to directors.

Was Carla S. Mashinski’s Primoris (PRIM) transaction a market purchase or a compensation grant?

The transaction was a compensation grant, not a market purchase. The Form 4 classifies it as a grant, award, or other acquisition of 294 common shares under Primoris’s non-employee director compensation program with no cash price per share paid.